Everyone Is Talking About GLP-1. Here's What You Actually Need to Know.
Semaglutide. Tirzepatide. Ozempic. Wegovy. Mounjaro. These names are everywhere — in medical journals, in Bollywood circles, in WhatsApp health groups. India's anti-obesity market grew 115% in 2025 on the back of GLP-1 drug launches. But the buzz has created as much confusion as clarity. Let's cut through it.
Who Are the Right Candidates?
What to Expect When You Start
GLP-1 isn't a pill you take and forget. Here's the honest picture:
Food "noise" — the constant mental chatter about what to eat next — quiets down meaningfully for most patients.
Nausea, mild bloating common in weeks 1–4. Starting at low dose and titrating slowly (MetaFit's protocol) minimizes these significantly.
0.5–1 kg per week typical early on. Clinical trials show 13–20% total body weight reduction over 12–18 months with lifestyle changes.
GLP-1 suppresses appetite. It doesn't teach healthy habits or fix sleep and stress. Combine it with MetaFit's coaching for optimal, lasting results.
The MetaFit Assessment Process
🔬 What Your MetaFit Evaluation Includes
A New Era of Weight Loss Medicine
For decades, the only effective medical options for obesity were bariatric surgery — invasive, expensive, and inaccessible to most Indians. GLP-1 medications represent the first time in medical history that a weekly injection can produce surgical-level weight loss outcomes safely and reversibly. This is genuinely historic. If you've been struggling with weight despite doing "everything right," this era was made for you.
The people who struggle most with weight are often those working hardest against the toughest biology. They deserve the best tools medicine has to offer.
Ready to Start Your Weight Loss Journey?
Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.
Book a Free ConsultationOr download the app to get started
